Mitsubishi Tanabe Pharma Development America Inc - NJ Hudson, Jersey City 07310

Mitsubishi Tanabe Pharma Development America Inc entered the industry of in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 325412, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.

To acquire more information, please contact Maxine Gallagher by calling (210) 256-9500 during business hours. You can also write to the business’ Single Location at 525 Wshngton Boulevard Floor 1400, Jersey City, New Jersey NJ 07310. You can also visit the company’s website at mitsubishi-pharma.eu.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Mitsubishi Tanabe Pharma Development America Inc
Representative: Maxine Gallagher
Place of Business: 525 Wshngton Boulevard Floor 1400, Jersey City, NJ 07310
Contact Number: (210) 256-9500
Website: mitsubishi-pharma.eu.com
Type of Service:
SIC Number: 2834
NAICS Number: 325412
Locality: Single Location
Market Type: B2B & B2C
Began: 2010
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Mitsubishi Tanabe Pharma Development America Inc is a company operating from Hudson, New Jersey providing professional and relevant BOTH variables. It was founded in 2010 and registered with the SIC code 2834 as , and with the NAICS code 325412 as .

With a current employee count of 1 to 4, Mitsubishi Tanabe Pharma Development America Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Maxine Gallagher at (210) 256-9500 for related queries, or to locate its Single Location using the coordinates 40.726964,-74.035019.

The Single Location can also be found at the street address 525 Wshngton Boulevard Floor 1400 in Jersey City, New Jersey 07310 and can be engaged online through the company website at mitsubishi-pharma.eu.com, the company Twitter , and Facebook page .